Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. 2002

Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-1019, USA. ivfrolov@utmb.edu

Alphaviruses productively infect a variety of vertebrate and insect cell lines. In vertebrate cells, Sindbis virus redirects cellular processes to meet the needs of virus propagation. At the same time, cells respond to virus replication by downregulating virus growth and preventing dissemination of the infection. The balance between these two mechanisms determines the outcome of infection at the cellular and organismal levels. In this report, we demonstrate that a viral nonstructural protein, nsP2, is a significant regulator of Sindbis virus-host cell interactions. This protein not only is a component of the replicative enzyme complex required for replication and transcription of viral RNAs but also plays a role in suppressing the antiviral response in Sindbis virus-infected cells. nsP2 most likely acts by decreasing interferon (IFN) production and minimizing virus visibility. Infection of murine cells with Sindbis virus expressing a mutant nsP2 leads to higher levels of IFN secretion and the activation of 170 cellular genes that are induced by IFN and/or virus replication. Secreted IFN protects naive cells against Sindbis virus infection and also stops viral replication in productively infected cells. Mutations in nsP2 can also attenuate Sindbis virus cytopathogenicity. Such mutants can persist in mammalian cells with defects in the alpha/beta IFN (IFN-alpha/beta) system or when IFN activity is neutralized by anti-IFN-alpha/beta antibodies. These findings provide new insight into the alphavirus-host cell interaction and have implications for the development of improved alphavirus expression systems with better antigen-presenting potential.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012845 Sindbis Virus The type species of ALPHAVIRUS normally transmitted to birds by CULEX mosquitoes in Egypt, South Africa, India, Malaya, the Philippines, and Australia. It may be associated with fever in humans. Serotypes (differing by less than 17% in nucleotide sequence) include Babanki, Kyzylagach, and Ockelbo viruses. Babanki virus,Kyzylagach virus,Ockelbo Virus
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity

Related Publications

Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
June 2006, Journal of virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
July 1989, Virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
July 1990, Virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
November 2007, Virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
February 1985, Journal of virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
May 1990, Journal of virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
November 1989, Journal of virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
August 1992, Virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
September 1994, Journal of virology,
Elena I Frolova, and Rafik Z Fayzulin, and Susan H Cook, and Diane E Griffin, and Charles M Rice, and Ilya Frolov
April 1993, Journal of virology,
Copied contents to your clipboard!